Comparison of the effects of glucagon-Like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus - Zelniker, TA; Wiviott, SD; Raz, I (Circulation, 2019)
doi:10.1161/CIRCULATIONAHA.118.038868